CD24, which is a regulator of cell migration, invasion, and proliferation in certain cancers, is often overexpressed in tumors and is a potential biomarker for breast cancers, as CD24 overexpression is associated with poor prognosis [42]. This evidence concerns the gene CD24 and breast cancer.